Getinge B stock holds steady as investors focus on its medtech base
Published on 07/13/2026 at 09:26 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Getinge B (ISIN SE0000202624) remains anchored in hospital-focused medical technology, with the company listed on Nasdaq Stockholm and organized around acute care and life science equipment.
Business profile
Getinge AB develops products used in operating rooms, intensive care, sterilization, and other clinical workflows, which gives the company exposure to long-cycle hospital budgets rather than consumer demand.
What matters now
For investors, the structural story is the mix of installed-base service revenue, capital equipment sales, and recurring demand from regulated healthcare customers. That combination often makes the business more stable than a pure equipment vendor, even when order timing can vary.
Product focus
A representative part of the portfolio is surgical and critical-care equipment that supports hospital procedures and patient monitoring. That product mix is the core of the Getinge B investment case.
Stock context
Getinge B trades on Nasdaq Stockholm in Swedish kronor. The shares are a large-cap Nordic healthcare name and fit the profile of a defensively oriented industrial-medtech holding.
Getinge B fact box
- Company: Getinge AB
- ISIN: SE0000202624
- Ticker: GETI B
- Exchange: Nasdaq Stockholm
- Sector / Industry: Health Care / Health Care Equipment & Supplies
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
